乳腺癌新辅助化疗对激素受体表达水平的影响Effects of Neoadjuvant Chemotherapy on Hormone Receptor Expression in Breast Cancer
刘胜翠, 刘 军
临床医学进展Vol.12 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.121101, January 29 2022
超重和肥胖与乳腺癌的发病及临床病理相关性研究Study on the Correlation between Overweight and Obesity and Breast Cancer Morbidity and Clinical Pathology
李雅薇, 张生军
临床医学进展Vol.11 No.9, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.119588, September 16 2021
乳腺导管原位癌伴微浸润的临床病理特点及远期预后Clinicopathological Features and Long-Term Prognosis of Breast Ductal Carcinoma in Situ with Microinvasion
纪涵青, 缪姗姗, 毛 艳, 吴 琍
临床医学进展Vol.12 No.2, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.122202, February 24 2022
3.0T动态增强MRI的背景实质增强和乳腺癌临床分期、分子病理类型及术后胸壁复发的相关性研究Correlation of BPE of 3.0T Dynamic Enhanced MRI and Clinical Stage, Molecular Pathological Type, Postoperative Chest Wall Recurrence of Breast Cancer
孙祥寅, 董银英, 陆海军, 孙 清, 周 静, 任瑞美
临床医学进展Vol.12 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.127915, July 13 2022
P63在HER2低表达乳腺癌中的表达及临床意义Expression and Clinical Significance of P63 in HER2 Low-Expression Breast Cancer
冯 月, 张立雪, 欧江华
临床医学进展Vol.13 No.12, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.13122621, December 5 2023
miRNA-200c和E-Cadherin在三阴性乳腺癌中的表达及意义Expression and Clinical Significance of miRNA-200 and E-Cadherin in Triple Negative Breast Carcinoma
彭 湃, 郑 凯, 陈梦荷, 胡超华, 韩运涛 科研立项经费支持
临床医学进展Vol.13 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2023.131069, January 19 2023